{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:37:44Z","timestamp":1770824264335,"version":"3.50.1"},"reference-count":55,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Context.\u2014New guidelines discourage cervical screening and procedures in young females, given available human papillomavirus vaccines, concerns regarding procedure-associated harms, and the rarity of cervical cancers.<\/jats:p>\n                  <jats:p>Objective.\u2014To analyze histopathologic follow-up data on a large number of young females with high-grade squamous intraepithelial lesion (HSIL) Papanicolaou (Pap) test results.<\/jats:p>\n                  <jats:p>Design.\u2014Hospital records were searched for HSIL Pap test results in females 20\u00a0years or younger between January 2002 and December 2007. Histopathologic and Pap test follow-up, age group variations, and impact of Pap test transformation zone\/endocervical sampling were analyzed.<\/jats:p>\n                  <jats:p>Results.\u2014Four hundred seventy-four females aged 20\u00a0years or younger had HSIL Pap test results during the study period. Three hundred thirty-five young females with at least one cervical biopsy were included. The average age was 18.6\u00a0years (range, 13\u201320\u00a0years). The average follow-up period was 24\u00a0months (range, 0.1\u201375\u00a0months), with a median of 22\u00a0months. Histopathologic detection rates were 44.2% for cervical intraepithelial neoplasia (CIN) 2\/3 and 47.8% for CIN 1. The average period between the HSIL Pap test result and an initial diagnosis of CIN 2\/3 was 5\u00a0months (range, 0.1\u201362\u00a0months), with a median of 2\u00a0months. Neither invasive carcinoma nor adenocarcinoma in situ was identified. Presence or absence of a transformation zone\/endocervical sample did not significantly impact CIN 2\/3 risk (44.5% versus 38.9%, P \u200a=\u200a .64).<\/jats:p>\n                  <jats:p>Conclusions.\u2014Histopathologic CIN 2\/3 was documented in 148 of 335 (44%) of biopsied young females with HSIL Pap results, likely reflecting both the reported high likelihood of HSIL regression in younger females and the challenge of colposcopic sampling of relatively short-lived smaller CIN 2\/3 lesions. Although no cases of invasive carcinoma were identified in this study, updated guidelines pose new risks for maturing females with undetected cervical precancer.<\/jats:p>","DOI":"10.5858\/2010-0121-oa.1","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T13:12:39Z","timestamp":1613135559000},"page":"361-364","source":"Crossref","is-referenced-by-count":14,"title":["Follow-up Findings in Young Females With High-Grade Squamous Intraepithelial Lesion Papanicolaou Test Results"],"prefix":"10.5858","volume":"135","author":[{"given":"Chengquan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pal","family":"Kalposi-Novak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Marshall","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"issue":"1","key":"2021021104112618900_i1543-2165-135-3-361-b01","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/LGT.0b013e3181cec411","article-title":"Practice improvements in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women","volume":"14","author":"Moscicki","year":"2010","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"2021021104112618900_i1543-2165-135-3-361-b02","first-page":"1409","article-title":"ACOG Practice Bulletin No.\u00a0109. American College of Obstetricians and Gynecologists","volume":"114","author":"Cervical Cytology Screening","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2021021104112618900_i1543-2165-135-3-361-b03","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/01.AOG.0000163254.98217.91","article-title":"Gynecologic malignancies in women aged less than 25\u00a0years","volume":"105","author":"You","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"10 suppl","key":"2021021104112618900_i1543-2165-135-3-361-b04","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/cncr.23756","article-title":"Burden of cervical cancer in the United States, 1998\u20132003","volume":"113","author":"Watson","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"2021021104112618900_i1543-2165-135-3-361-b05","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3476(98)70445-7","article-title":"The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women","volume":"132","author":"Moscicki","year":"1998","journal-title":"J Pediatr"},{"issue":"2","key":"2021021104112618900_i1543-2165-135-3-361-b06","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/archpedi.154.2.127","article-title":"Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus","volume":"154","author":"Mosicki","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"2021021104112618900_i1543-2165-135-3-361-b07","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.AOG.0000165822.29451.54","article-title":"Cervical dysplasia in adolescents","volume":"106","author":"Wright","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2021021104112618900_i1543-2165-135-3-361-b08","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/bjc.1996.441","article-title":"Forty years of repeated screening: the significance of carcinoma in situ","volume":"74","author":"Morrison","year":"1996","journal-title":"Br J Cancer"},{"issue":"5","key":"2021021104112618900_i1543-2165-135-3-361-b09","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jpag.2007.04.012","article-title":"Management of cervical intraepithelial neoplasia 2 in adolescent and young women","volume":"20","author":"Fuch","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"2021021104112618900_i1543-2165-135-3-361-b10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.AOG.0000151991.09124.bb","article-title":"The effect of loop electrosurgical excision","volume":"105","author":"Samson","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"17","key":"2021021104112618900_i1543-2165-135-3-361-b11","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1001\/jama.291.17.2100","article-title":"Treatment for cervical intraepithelial neoplasia and risk of preterm delivery","volume":"291","author":"Sadler","year":"2004","journal-title":"JAMA"},{"issue":"9509","key":"2021021104112618900_i1543-2165-135-3-361-b12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"issue":"19","key":"2021021104112618900_i1543-2165-135-3-361-b13","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"9580","key":"2021021104112618900_i1543-2165-135-3-361-b14","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"issue":"9686","key":"2021021104112618900_i1543-2165-135-3-361-b15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"2021021104112618900_i1543-2165-135-3-361-b16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"issue":"7609","key":"2021021104112618900_i1543-2165-135-3-361-b17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.39219.645475.55","article-title":"Accuracy of reading liquid based cytology slides using the ThinPrep imager compared with conventional cytology: prospective study [published online ahead of print June 29, 2007]","volume":"335","author":"Davey","year":"2007","journal-title":"BMJ"},{"issue":"2","key":"2021021104112618900_i1543-2165-135-3-361-b18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2007.06.025","article-title":"Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone","volume":"107","author":"Zhao","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"4","key":"2021021104112618900_i1543-2165-135-3-361-b19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/cncr.23598","article-title":"Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical\/transformation zone sample","volume":"114","author":"Zhao","year":"2008","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"2021021104112618900_i1543-2165-135-3-361-b20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2009.05.019","article-title":"Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods","volume":"114","author":"Zhao","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"12","key":"2021021104112618900_i1543-2165-135-3-361-b21","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.5858\/132.12.1874","article-title":"Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results","volume":"132","author":"Bandyopadhyay","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"2021021104112618900_i1543-2165-135-3-361-b22","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.5858\/133.9.1426","article-title":"Follow-up findings for women with human papillomavirus-positive and atypical squamous cells of undetermined significance screening test results in a large women's hospital practice","volume":"133","author":"Armah","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"2021021104112618900_i1543-2165-135-3-361-b23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.22949","article-title":"Very low human papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests","volume":"111","author":"Zhao","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"2021021104112618900_i1543-2165-135-3-361-b24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ygyno.2009.07.010","article-title":"High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older","volume":"115","author":"Bansal","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2021021104112618900_i1543-2165-135-3-361-b25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1309\/GCVB5C4KFV7TFC7F","article-title":"Laboratory management of CIN 2: the consensus is consensus","volume":"130","author":"Crum","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2021021104112618900_i1543-2165-135-3-361-b26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1309\/AJCPXSVCDZ3D5MZM","article-title":"Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia","volume":"133","author":"Bergeron","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"2021021104112618900_i1543-2165-135-3-361-b27","first-page":"765","article-title":"Changes in cervical cancer incidence after three decades of screening US women less than 30\u00a0years old","volume":"102","author":"Chan","year":"2003","journal-title":"Obstet Gynecol"},{"key":"2021021104112618900_i1543-2165-135-3-361-b28","article-title":"Cervical cancer screening in adolescents (women &lt;21\u00a0years of age)","author":"American Society of Cytopathology"},{"issue":"3","key":"2021021104112618900_i1543-2165-135-3-361-b29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1158\/1055-9965.EPI-08-1012","article-title":"Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women","volume":"18","author":"Trottier","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"2021021104112618900_i1543-2165-135-3-361-b30","first-page":"523","article-title":"Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22\u200a439 correlations in 348 laboratories","volume":"120","author":"Jones","year":"1996","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"2021021104112618900_i1543-2165-135-3-361-b31","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/ijc.24779","article-title":"Why young women should be screened for cervical cancer: the distinction between CIN2 and CIN3","volume":"126","author":"Herbert","year":"2010","journal-title":"Int J Cancer"},{"issue":"9","key":"2021021104112618900_i1543-2165-135-3-361-b32","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/ijc.24785","article-title":"Response to: why young women should be screened for cervical cancer: the distinction between CIN2 and CIN3","volume":"126","author":"Sasieni","year":"2010","journal-title":"Int J Cancer"},{"issue":"4","key":"2021021104112618900_i1543-2165-135-3-361-b33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpag.2008.05.005","article-title":"A 6-year experience with Pap smears in an urban adolescent practice: the scope and burden of abnormalities","volume":"22","author":"Soren","year":"2009","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"2021021104112618900_i1543-2165-135-3-361-b34","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.ajog.2007.03.029","article-title":"Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes","volume":"197","author":"Moore","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2021021104112618900_i1543-2165-135-3-361-b35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.lgt.0000179862.75198.3d","article-title":"Risk of high-grade cervical intraepithelial neoplasia among young women with abnormal screening cytology","volume":"9","author":"Massad","year":"2005","journal-title":"J Low Genit Tract Dis"},{"issue":"9446","key":"2021021104112618900_i1543-2165-135-3-361-b36","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","article-title":"Regression of low-grade squamous intra-epithelial lesions in young women","volume":"364","author":"Moscicki","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"2021021104112618900_i1543-2165-135-3-361-b37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1542\/peds.103.3.539","article-title":"A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England","volume":"103","author":"Mount","year":"1999","journal-title":"Pediatrics"},{"issue":"6","key":"2021021104112618900_i1543-2165-135-3-361-b38","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/AOG.0b013e3181ac06e0","article-title":"ACOG Committee Opinion No.\u00a0436: evaluation and management of abnormal cytology and histology in adolescents","volume":"113","author":"Committee on Adolescent Health Care","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2021021104112618900_i1543-2165-135-3-361-b39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2021021104112618900_i1543-2165-135-3-361-b40","first-page":"372","article-title":"Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias","volume":"12","author":"Sherman","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"2021021104112618900_i1543-2165-135-3-361-b41","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/AOG.0b013e3181792420","article-title":"More questions about the accuracy of colposcopy: what does this mean for cervical cancer prevention","volume":"111","author":"Cox","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2021021104112618900_i1543-2165-135-3-361-b42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ajog.2008.12.025","article-title":"Colposcopy to evaluate abnormal cervical cytology in 2008","volume":"200","author":"Chase","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021021104112618900_i1543-2165-135-3-361-b43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.AOG.0000220505.18525.85","article-title":"Number of cervical biopsies and sensitivity of colposcopy","volume":"108","author":"Gage","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2021021104112618900_i1543-2165-135-3-361-b44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1309\/J31A0YQM37Q4V4KK","article-title":"ASC, TBS, and the power of ALTS","volume":"127","author":"Stoler","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"2021021104112618900_i1543-2165-135-3-361-b45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00006250-200308000-00045","article-title":"Cervical cytology screening. Clinical management guidelines for obstetrician-gynecologists. No.\u00a045, August 2003","volume":"102","author":"ACOG Practice Bulletin","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2021021104112618900_i1543-2165-135-3-361-b46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guideline for the early detection of cervical neoplasia and cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2021021104112618900_i1543-2165-135-3-361-b47","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2009.04.005","article-title":"The impact of human papillomavirus vaccination on cervical cancer prevention efforts","volume":"114","author":"Massad","year":"2009","journal-title":"Gynecol Oncol"},{"key":"2021021104112618900_i1543-2165-135-3-361-b48","doi-asserted-by":"crossref","first-page":"b2968","DOI":"10.1136\/bmj.b2968","article-title":"Effectiveness of cervical screening with age: population-based case-control study of prospectively recorded data","volume":"339","author":"Sasieni","year":"2009","journal-title":"BMJ"},{"issue":"7188","key":"2021021104112618900_i1543-2165-135-3-361-b49","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/bmj.318.7188.904","article-title":"Effect of screening on incidence and mortality from cancer of cervix in England: evaluation based on routinely collected statistics","volume":"318","author":"Quinn","year":"1999","journal-title":"BMJ"},{"key":"2021021104112618900_i1543-2165-135-3-361-b50","first-page":"1","article-title":"U-turn on cervical cancer tests for young women: ministers rethink decision to cut routine screening for under-25s","author":"Brady","year":"6, 2009","journal-title":"Independent"},{"issue":"5","key":"2021021104112618900_i1543-2165-135-3-361-b51","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1018435522475","article-title":"International incidence rates of cervical cancer after introduction of cytological screening","volume":"8","author":"Gustafsson","year":"1997","journal-title":"Cancer Causes Control"},{"issue":"5","key":"2021021104112618900_i1543-2165-135-3-361-b52","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bjc.6605528","article-title":"Predicted impact of vaccination against human papillomavirus 16\/18 on cancer incidence and cervical abnormalities in women aged 20\u201329 in the UK","volume":"102","author":"Cuzick","year":"2010","journal-title":"Br J Cancer"},{"issue":"1","key":"2021021104112618900_i1543-2165-135-3-361-b53","first-page":"29","article-title":"Screening interval and risk of invasive squamous cell cervical cancer","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2021021104112618900_i1543-2165-135-3-361-b54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000326498","article-title":"Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening","volume":"47","author":"Kinney","year":"2003","journal-title":"Acta Cytol"},{"issue":"36","key":"2021021104112618900_i1543-2165-135-3-361-b55","first-page":"997","article-title":"National, state, and local area vaccination coverage among adolescents aged 13\u201317\u00a0years\u2014United States, 2008","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/135\/3\/361\/2770710\/2010-0121-oa_1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/135\/3\/361\/2770710\/2010-0121-oa_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:38:17Z","timestamp":1764790697000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/135\/3\/article-p361.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3,1]]}},"URL":"https:\/\/doi.org\/10.5858\/2010-0121-oa.1","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}